BIOLASE Inc. (BIOL) - Utang marang Ekuitas

BIOL (BIOLASE, Inc.) - tandha merek perusahaan

This chart illustrates the market price reflecting the total debt-to-equity ratio of BIOLASE, Inc. (BIOL), which stands at 0.00. Stability in these metrics is supported by strict FDA oversight and exclusive patents for laser systems. Its status as a global leader enables the company to maintain significant pricing power due to the painless nature of its procedures. Production also relies on compliance with RoHS standards for the disposal of electronic components.

biolase.com - Utang marang Modal BIOL (periode 04.07.2022 - 04.08.2024)

Rincian analitis lan laporan data perusahaan Biolase Inc. (BIOL)

- rega lan prakiraan konsensus rega:
Bagan rega BIOLASE|BIOL - Target median analis
- data kapitalisasi pasar:
Nilai pasar BIOLASE|BIOL - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham BIOLASE|BIOL - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku biolase.com|BIOL - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal BIOLASE, Inc.|BIOL - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal BIOLASE, Inc.|BIOL - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku BIOLASE|BIOL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan BIOLASE
Ringkesan analisis perusahaan:BIOL, BIOLASE
Barang unggulan Biolase Inc.

This ratio determines financial stability by comparing total credit obligations against equity to assess the business's degree of dependence on borrowed funds. By analyzing the company's leverage relative to equity, an investor can see the balance between the debt load and the resources that BIOLASE, Inc. (BIOL) allocates toward the development of laser systems through strategic partnerships with global dental associations.

Pesaing utama

BSX: Utang marang Ekuitas|Koefisien Total Utang marang Modal EW|RMD - Utang marang Ekuitas|Utang Agregat marang Ekuitas Insulet Inc. (PODD)|ZBH: Total Utang marang Modal|Utang marang Modal coopercos.com COO|ALGN: Total Utang marang Modal|GMED - Rasio Total Utang marang Ekuitas|TransMedics - Total Utang marang Modal|Alphatec Corp (ATEC) - Koefisien Total Utang marang Modal|AORT (Artivion, Inc.) - Total Utang marang Modal|Total Utang marang Modal ENOV|Utang marang Ekuitas Integra LifeSciences Holdings Corporation (IART)|Utang marang Ekuitas Establishment Labs Corp (ESTA)|Total Utang marang Modal BBNX|IRMD - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas Embecta Corp.|TNDM - Utang Agregat marang Ekuitas|Total Utang marang Modal AXGN|SI-BONE Inc (SIBN) - Utang marang Modal|Total Utang marang Modal Orthofix International (OFIX)|Rasio Utang marang Ekuitas Bioventus Global (BVS)|OrthoPediatrics Corp. (KIDS) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi TMCI (treace.com)|Strata Critical Medical - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Carlsmed, Inc. CARL|RXST (RxSight Corp) - Total Utang marang Modal|CLPT - Utang marang Modal|Total Utang marang Modal Stereotaxis, Inc.|neurostar.com (STIM) - Rasio Utang marang Ekuitas|SGHT: Total Utang marang Modal|Koefisien Total Utang marang Modal Orchestra BioMed Inc.|Total Utang marang Modal ANIK (Anika Therapeutics)|Rasio Total Utang marang Ekuitas InspireMD Inc. (NSPR)|Total Utang marang Modal ZJYL (Jin Medical)|Vivani Medical Inc - Total Utang marang Modal|XTNT - Utang marang Ekuitas|NeuroOne (NMTC) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas modular-medical.com MODD|Myomo Inc (MYO) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal COCH (Envoy Medical, Inc.)|Utang marang Modal VVOS|NVNO: Utang marang Ekuitas|Rasio Utang marang Modal sintx.com SINT|Rasio Total Utang marang Ekuitas TNON (Tenon Medical, Inc)|Total Utang marang Modal Lifeward Ltd. LFWD|Total Utang marang Modal AMIX (Autonomix)|IVF: Koefisien Total Utang marang Modal|Utang marang Ekuitas Bone Biologics Corp (BBLG)|AXNX (Axonics Inc.) - Utang Agregat marang Ekuitas|Utang marang Ekuitas DYNT|Rasio Total Utang marang Ekuitas Paragon 28 Corp|INVO Bioscience, Inc. - Total Utang marang Modal